Overview
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence
Status:
NOT_YET_RECRUITING
NOT_YET_RECRUITING
Trial end date:
2031-08-11
2031-08-11
Target enrollment:
Participant gender: